Digital diet study aims to boost GLP-1 results
NCT ID NCT07481305
First seen Mar 30, 2026 · Last updated May 24, 2026 · Updated 10 times
Summary
This study will test whether the Noom digital lifestyle program helps adults who are taking GLP-1 medications (like Wegovy or Ozempic) improve their diet and physical activity. About 220 participants will use the program for 4 months while wearing a Fitbit to track activity. The goal is to see if adding lifestyle support can enhance health outcomes for people managing their weight with these medications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLP-1 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UMass Chan Medical School
Worcester, Massachusetts, 01655, United States
Conditions
Explore the condition pages connected to this study.